| Development of the Kidney Disease Quality of Life (KDQOLTM) Instrument RD Hays, JD Kallich, DL Mapes, SJ Coons, WB Carter Quality of life Research 3, 329-338, 1994 | 1504 | 1994 |
| Kidney Disease Quality of Life Short From (KDQOL-SF^< TM>), Version 1.2 RD Hays A manual for use and scoring, P1-39, 1997 | 680* | 1997 |
| User's manual for the Medical Outcomes Study (MOS) core measures of health-related quality of life CD Sherbourne, RD Hays, R Mazel Rand Corporation, 1995 | 478 | 1995 |
| The longitudinal relationship of hemoglobin, fatigue and quality of life in anemic cancer patients: results from five randomized clinical trials D Cella, J Kallich, A McDermott, X Xu Annals of Oncology 15 (6), 979-986, 2004 | 293 | 2004 |
| Health care costs for patients with cancer at the end of life B Chastek, C Harley, J Kallich, L Newcomer, CJ Paoli, AH Teitelbaum Journal of oncology practice 8 (6S), 75s-80s, 2012 | 265 | 2012 |
| Kidney Disease Quality of Life Short Form (KDQOL-SF™), version 1.3: a manual for use and scoring RD Hays, JD Kallich, DL Mapes, SJ Coons, N Amin, WB Carter, ... Santa Monica: RAND, 7994, 1997 | 220 | 1997 |
| Kidney Disease Quality of Life Short Form (KDQOL-SF™), version 1.3: a manual for use and scoring RD Hays, JD Kallich, DL Mapes, SJ Coons, N Amin, WB Carter, ... Santa Monica: RAND, 7994, 1997 | 220 | 1997 |
| Kidney Disease Quality of Life Short Form (KDQOL-SF™), version 1.3: a manual for use and scoring RD Hays, JD Kallich, DL Mapes, SJ Coons, N Amin, WB Carter, ... Santa Monica: RAND, 7994, 1997 | 220 | 1997 |
| Kidney Disease Quality of Life Short Form (KDQOL-SF™), version 1.3: a manual for use and scoring RD Hays, JD Kallich, DL Mapes, SJ Coons, N Amin, WB Carter, ... Santa Monica: RAND, 7994, 1997 | 220 | 1997 |
| Patient-reported outcomes: instrument development and selection issues RR Turner, AL Quittner, BM Parasuraman, JD Kallich, CS Cleeland, ... Value in Health 10, S86-S93, 2007 | 194 | 2007 |
| A review of health-related quality-of-life measures used in end-stage renal disease ET Edgell, SJ Coons, WB Carter, JD Kallich, D Mapes, TM Damush, ... Clinical therapeutics 18 (5), 887-938, 1996 | 184 | 1996 |
| Dissemination of effectiveness and outcomes research DE Kanouse, JD Kallich, JP Kahan Health policy 34 (3), 167-192, 1995 | 126 | 1995 |
| The relationship between psychologic distress and cancer‐related fatigue NS Tchekmedyian, J Kallich, A McDermott, P Fayers, MH Erder Cancer 98 (1), 198-203, 2003 | 124 | 2003 |
| Platelet transfusions: utilization and associated costs in a tertiary care hospital KR Meehan, CO Matias, SS Rathore, SG Sandler, J Kallich, J LaBrecque, ... American journal of hematology 64 (4), 251-256, 2000 | 110 | 2000 |
| An evaluation of algorithms for identifying metastatic breast, lung, or colorectal cancer in administrative claims data JL Whyte, NM Engel-Nitz, A Teitelbaum, GG Rey, JD Kallich Medical care 53 (7), e49-e57, 2015 | 99 | 2015 |
| Identification of metastatic cancer in claims data BL Nordstrom, JL Whyte, M Stolar, C Mercaldi, JD Kallich Pharmacoepidemiology and drug safety 21, 21-28, 2012 | 88 | 2012 |
| The economic burden of anemia in cancer patients receiving chemotherapy GH Lyman, ER Berndt, JD Kallich, MH Erder, WH Crown, SR Long, H Lee, ... Value in health 8 (2), 149-156, 2005 | 88 | 2005 |
| Development of subscales from the symptoms/problems and effects of kidney disease scales of the kidney disease quality of life instrument S Rao, WB Carter, DL Mapes, JD Kallich, CJ Kamberg, KL Spritzer, ... Clinical therapeutics 22 (9), 1099-1111, 2000 | 88 | 2000 |
| Psychological outcomes associated with anemia-related fatigue in cancer patients. JD Kallich, NS Tchekmedyian, AM Damiano, J Shi, JT Black, MH Erder Oncology (Williston Park, NY) 16 (9 Suppl 10), 117-124, 2002 | 67 | 2002 |
| Medication adherence and fracture risk among patients on bisphosphonate therapy in a large United States health plan SW Wade, JR Curtis, J Yu, J White, BS Stolshek, C Merinar, ... Bone 50 (4), 870-875, 2012 | 64 | 2012 |
Ron D. HaysUCLAVerified email at ucla.edu
